[Form 4] Envoy Medical, Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

07/08/2025 - 10:37 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TAYLOR GLEN A

(Last)

(First)

(Middle)

C/O 4875 WHITE BEAR PARKWAY

(Street)

WHITE BEAR LAKE

55110

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Envoy Medical, Inc. [ COCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock								2,953,607	D
Class A Common Stock								2,526,058	I	By Taylor Sports Group⁽¹⁾
Class A Common Stock								4,810,384	I	By GAT Funding, LLC⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Preferred Stock	$11.5							⁽³⁾	⁽³⁾	Class A Common Stock	869,565		1,000,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$1.24							02/27/2024	02/27/2026	Class A Common Stock	500,000		500,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$3.04							05/23/2024	02/27/2026	Class A Common Stock	250,000		250,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$2.25							07/22/2024	02/27/2026	Class A Common Stock	250,000		250,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$2.97							08/27/2024	08/27/2026	Class A Common Stock	500,000		500,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$2.2							12/11/2024	08/27/2026	Class A Common Stock	500,000		500,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$1.35							03/11/2025	03/11/2028	Class A Common Stock	750,000		750,000	I	GAT Funding, LLC⁽²⁾
Warrant (right to buy)	$1.48	06/26/2025		A		750,000⁽⁴⁾		06/26/2025	06/26/2027	Class A Common Stock	750,000	$0	750,000	I	GAT Funding, LLC⁽²⁾

Explanation of Responses:

1. The Reporting Person is the owner and chairman of Taylor Sports Group.

2. GAT Funding, LLC is an entity controlled by the Reporting Person.

3. Fully exercisable and there is no expiration date.

4. In connection with the promissory note issuance effective March 6, 2025 and the closing of the final funding on June 26, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on July 2, 2025.

	/s/ Andrew Nick as Attorney-in-Fact for Glen A. Taylor pursuant to a Power of Attorney previously filed	07/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

AG真人官方